Drawing for ALL ABOUT NERVE REPAIR

USPTO serial 88211032

ALL ABOUT NERVE REPAIR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ANDERSON, CASSONDRA CR
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALL ABOUT NERVE REPAIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brad Ottinger

Brad Ottinger Axogen Corporation13631 Progress Blvd., Suite 400Alachua, FL 32615UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human and animal tissue, for medical and veterinary use; surgical glues; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; medical and veterinary instruments and devices, namely, nerve and tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regenerationACTIVE—
010Medical, veterinary and diagnostic instruments for use in regenerative medicine, wound repair, surgical repair, and nerve repair and regeneration; nervous tissue products for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration, namely, surgical kits comprised of medical, veterinary and surgical apparatus for use in the field of surgery, namely, medical, veterinary and diagnostic instruments for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration, sutures, dressing, forceps and medical and veterinary instruments for cutting tissue, surgical implants comprised of biological tissue; surgical implants comprised of synthetic materials; sensory testing instruments, namely, aesthesiometers and two-point discriminators; medical and veterinary devices, namely, devices for measuring threshold somatosensory and nerve density in humans and vertebrates; medical devices for measuring human hand's pinch strength; medical and veterinary devices, namely, a nerve function assessment monitor for use in measuring and evaluating sensory and motor function; monitoring system for medical and veterinary use comprised of components measuring pressure sensitivity on the skin, and grip and pinch strength of patients; medical and veterinary instruments and devices, namely, nerve and tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; implants comprising synthetic materialACTIVE—
038Providing an online forum for discussion by surgeons on a variety of topics relevant in the surgical community in the medical and veterinary fieldsACTIVE—
042Scientific research for medical and veterinary purposes in the area of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; scientific research for medical and veterinary purposes in the field of plastic, orthopedic, neurology, urology, and/or ENT surgery; providing medical, veterinary and scientific research information relating to medical and veterinary treatment in the nature of results of scientific research and clinical data in the areas of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and pharmaceutical and veterinary preparations and delivery therefor provided through a database that allows input and collection of data and information; clinical research in the areas of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and pharmaceutical and veterinary preparations and delivery systems, to provide information on functional recovery and treatment outcomes; research and development of new products and procedures in the pharmaceutical, veterinary and biotechnology fields; development of new technology for others in the fields of pharmaceutical and veterinary preparations and delivery systems therefor, regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and tissue generation, processing and transplantationACTIVE—
044Providing medical and veterinary procedures, namely, regenerative medicine treatment, wound repair, surgical repair, neurotizing breast construction, nerve repair and regeneration, and administration of pharmaceutical and veterinary preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 2, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 2, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 17, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2021EX2GSOU EXTENSION 2 GRANTED—
Feb 13, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Feb 12, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Feb 12, 2021PETGPETITION TO REVIVE-GRANTED—
Feb 12, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Feb 1, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 1, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 8, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 8, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 8, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 8, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 31, 2020EXT2SOU EXTENSION 2 FILED—
Oct 8, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 7, 2020EX1GSOU EXTENSION 1 GRANTED—
Oct 6, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 17, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Aug 17, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Aug 17, 2020PETGPETITION TO REVIVE-GRANTED—
Aug 17, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Aug 3, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 3, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 30, 2020EXT1SOU EXTENSION 1 FILED—
Apr 23, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 23, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 23, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 23, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 31, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 2, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 1, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 12, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 12, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 2019ALIEASSIGNED TO LIE—
Sep 3, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 1, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 1, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 1, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2019DOCKASSIGNED TO EXAMINER—
Dec 17, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 3, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance